Advertisement

Topics

Will Part B step edits impact US biosimilar uptake?

11:28 EDT 23 Aug 2018 | Pharmaceutical Technology

Increased autonomy awarded to Medicare Advantage (MA) plans by the Centers for Medicare and Medicaid Services (CMS) to introduce step...
Read More...

The post Will Part B step edits impact US biosimilar uptake? appeared first on Pharmaceutical Technology.

Original Article: Will Part B step edits impact US biosimilar uptake?

NEXT ARTICLE

More From BioPortfolio on "Will Part B step edits impact US biosimilar uptake?"

Advertisement
Quick Search
Advertisement
Advertisement